Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Qingdao NovelBeam Technology Co EV-to-FCF?
Qingdao NovelBeam Technology CoSHSE:688677 -0.47%90 EV-to-FCF is 66.54 as of Jul. 27, 2026, which is 9% below its 10-year median of 72.85. GuruFocus rates SHSE:688677 with a GF Score™ of 90/100 and a GF Value™ of ¥63.03 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 416 Medical Devices & Instruments companies, Qingdao NovelBeam Technology Co ranks worse than 81.97% on this metric.
The historical rank and industry rank for Qingdao NovelBeam Technology Co's EV-to-FCF or its related term are showing as below:
SHSE:688677'
s EV-to-FCF Range Over the Past 10 Years
Min: -693.25 Med: 72.85 Max: 3718.15
Current: 66.54
During the past 13 years, the highest EV-to-FCF of Qingdao NovelBeam Technology Co was 3718.15. The lowest was -693.25. And the median was 72.85.
SHSE:688677's EV-to-FCF is ranked worse than 81.97% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 22.955
vs SHSE:688677: 66.54
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Qingdao NovelBeam Technology Co (SHSE:688677) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Qingdao NovelBeam Technology Co's PE Ratio (TTM) for today is calculated as:
Qingdao NovelBeam Technology Co's share price for today is ¥72.48.
Qingdao NovelBeam Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.450.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Qingdao NovelBeam Technology Co EV-to-FCF Related Terms
Qingdao NovelBeam Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688677 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Qingdao NovelBeam Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qingdao NovelBeam Technology Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qingdao NovelBeam Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Qingdao NovelBeam Technology Co's EV-to-FCF falls into.
Qingdao NovelBeam Technology Co's current Enterprise Value is ¥8,180.0 Mil.
Qingdao NovelBeam Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥122.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qingdao NovelBeam Technology Co (SHSE:688677) has a EV-to-FCF of 66.54 as of Jul. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Qingdao NovelBeam Technology Co and its competitors. This is near median its historical median of 72.85. According to the industry distribution chart, Qingdao NovelBeam Technology Co ranks #341 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 82%.
Is Qingdao NovelBeam Technology Co's EV-to-FCF too high?
Qingdao NovelBeam Technology Co's current EV-to-FCF of 66.54 is near median its 10-year median of 72.85. The Medical Devices & Instruments industry median EV-to-FCF is 22.96. Qingdao NovelBeam Technology Co's value of 66.54 is 189.9% above this industry median. Based on the distribution chart, Qingdao NovelBeam Technology Co ranks #341 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Qingdao NovelBeam Technology Co has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao NovelBeam Technology Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Qingdao NovelBeam Technology Co ranks #341 out of 416 companies for EV-to-FCF. This places Qingdao NovelBeam Technology Co in the lower half of its industry. The industry median EV-to-FCF is 22.96. Qingdao NovelBeam Technology Co's value of 66.54 is 189.9% above this benchmark. While the company's 10-year median is 72.85 vs. the industry median of 22.96, Qingdao NovelBeam Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.96, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qingdao NovelBeam Technology Co's current EV-to-FCF of 66.54 is 189.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Qingdao NovelBeam Technology Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qingdao NovelBeam Technology Co's current EV-to-FCF is 66.54, which is near median its own 10-year median of 72.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao NovelBeam Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao NovelBeam Technology Co (SHSE:688677) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥63.03, compared to a current price of ¥72.48 — trading 15% above its estimated fair value. The current EV-to-FCF is 66.54, which is near median its 10-year median of 72.85 and 189.9% above the Medical Devices & Instruments industry median of 22.96. Qingdao NovelBeam Technology Co's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Qingdao NovelBeam Technology Co (SHSE:688677), the current EV-to-FCF is 66.54 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qingdao NovelBeam Technology Co (SHSE:688677) Overvalued in 2026?
Based on GuruFocus' analysis, Qingdao NovelBeam Technology Co stock appears to be overvalued.
The current stock price of ¥72.48 is trading 15% above its estimated GF Value™ of ¥63.03.
GuruFocus considers Qingdao NovelBeam Technology Co to be Modestly Overvalued.
Key valuation signals for SHSE:688677:
EV-to-FCF: 66.54 (near median its 10-year median of 72.85)
GF Value™: ¥63.03 vs. price of ¥72.48 (15% above fair value)
Industry Position: 189.9% above the Medical Devices & Instruments median (#341 of 416)
No single metric tells the full story. See the SHSE:688677 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qingdao NovelBeam Technology Co Business Description
Qingdao NovelBeam Technology Co Ltd is engaged in the research and development, production and sales of medical endoscope equipment and optical products. The product portfolio of the group includes Endoscope, Camera coupler, Camera lens, Medical optics, Biometrics and others.
90GF Score
Get the complete analysis for SHSE:688677
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688677 has been successfully added to your 
